RET Inhibitors in Non-Small-Cell Lung Cancer

by Priscilla Cascetta, Vincenzo Sforza, Anna Manzo, Guido Carillio, Giuliano Palumbo, Giovanna Esposito, Agnese Montanino, Raffaele Costanzo, Claudia Sandomenico, Rossella De Cecio, Maria Carmela Piccirillo, Carmine La Manna, Giuseppe Totaro, Paolo Muto, Carmine Picone, Roberto Bianco, Nicola Normanno, Alessandro Morabito
Published 2021-09-01

Current Guidelines for Management of Medullary Thyroid Carcinoma

by Mijin Kim, Bo Hyun Kim
Published 2021-06-01

Chasing the Target: New Phenomena of Resistance to Novel Selective RET Inhibitors in Lung Cancer. Updated Evidence and Future Perspectives

by Sara Fancelli, Enrico Caliman, Francesca Mazzoni, Marco Brugia, Francesca Castiglione, Luca Voltolini, Serena Pillozzi, Lorenzo Antonuzzo
Published 2021-03-01

Catalog of 5′ fusion partners in RET+ NSCLC Circa 2020

by Sai-Hong Ignatius Ou, MD, PhD, Viola W. Zhu, MD, PhD
Published 2020-06-01

RET Fusion: Joining the Ranks of Targetable Molecular Drivers in NSCLC

by Badi El Osta, MD, Suresh S. Ramalingam, MD, FACP, FASCO
Published 2020-09-01